Literature DB >> 20566726

Newly diagnosed diabetes mellitus as a risk factor for serious liver disease.

Liane Porepa1, Joel G Ray, Paula Sanchez-Romeu, Gillian L Booth.   

Abstract

BACKGROUND: The negative impact of diabetes mellitus is well recognized, yet little is known about the effect of this disease on the liver, an organ susceptible to nonalcoholic fatty liver disease related to insulin resistance. We evaluated whether adults with newly diagnosed diabetes were at increased risk of serious liver disease.
METHODS: We used administrative health databases for the province of Ontario (1994-2006) to perform a population-based matched retrospective cohort study. The exposed group comprised 438 069 adults with newly diagnosed diabetes. The unexposed comparison group--those without known diabetes--consisted of 2 059 708 individuals, matched 5:1 to exposed persons, by birth year, sex and local health region. We excluded individuals with pre-existing liver or alcohol-related disease. The primary study outcome was the subsequent development of serious liver disease, namely, liver cirrhosis, liver failure and its sequelae, or receipt of a liver transplant.
RESULTS: The incidence rate of serious liver disease was 8.19 per 10 000 person-years among those with newly diagnosed diabetes and 4.17 per 10 000 person-years among those without diabetes. The unadjusted hazard ratio was 1.92 (95% confidence interval [CI] 1.83-2.01). After adjustment for age, income, urban residence, health care utilization and pre-existing hypertension, dyslipidemia, obesity and cardiovascular disease, the hazard ratio was 1.77 (95% CI 1.68-1.86).
INTERPRETATION: Adults with newly diagnosed diabetes appeared to be at higher risk of advanced liver disease, also known as diabetic hepatopathy. Whether this reflects nonalcoholic fatty liver disease or direct glycemic injury of the liver remains to be determined.

Entities:  

Mesh:

Year:  2010        PMID: 20566726      PMCID: PMC2917963          DOI: 10.1503/cmaj.092144

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  29 in total

1.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001.

Authors:  Ali H Mokdad; Earl S Ford; Barbara A Bowman; William H Dietz; Frank Vinicor; Virginia S Bales; James S Marks
Journal:  JAMA       Date:  2003-01-01       Impact factor: 56.272

2.  Contribution of reduced insulin sensitivity and secretion to the pathogenesis of hepatogenous diabetes: effect of liver transplantation.

Authors:  G Perseghin; V Mazzaferro; L P Sereni; E Regalia; S Benedini; E Bazzigaluppi; A Pulvirenti; A A Leão; G Calori; R Romito; D Baratti; L Luzi
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

3.  Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.

Authors:  Frederico G S Toledo; Allan D Sniderman; David E Kelley
Journal:  Diabetes Care       Date:  2006-08       Impact factor: 19.112

4.  The disease burden associated with overweight and obesity.

Authors:  A Must; J Spadano; E H Coakley; A E Field; G Colditz; W H Dietz
Journal:  JAMA       Date:  1999-10-27       Impact factor: 56.272

5.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease.

Authors:  Kerry L Donnelly; Coleman I Smith; Sarah J Schwarzenberg; Jose Jessurun; Mark D Boldt; Elizabeth J Parks
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

6.  Race and comorbid factors predict nonalcoholic fatty liver disease histopathology in severely obese patients.

Authors:  Steven F Solga; Jeanne M Clark; Amir R Alkhuraishi; Michael Torbenson; Alireza Tabesh; Michael Schweitzer; Anna Mae Diehl; Thomas H Magnuson
Journal:  Surg Obes Relat Dis       Date:  2005 Jan-Feb       Impact factor: 4.734

Review 7.  Diabetes mellitus, obesity, and hepatic steatosis.

Authors:  Wael Youssef; Arthur J McCullough
Journal:  Semin Gastrointest Dis       Date:  2002-01

Review 8.  Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management.

Authors:  Diego Garcia-Compean; Joel Omar Jaquez-Quintana; Jose Alberto Gonzalez-Gonzalez; Hector Maldonado-Garza
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

9.  Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population.

Authors:  M E Allison; T Wreghitt; C R Palmer; G J Alexander
Journal:  J Hepatol       Date:  1994-12       Impact factor: 25.083

10.  Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease.

Authors:  Wolfram Goessling; Joseph M Massaro; Ramachandran S Vasan; Ralph B D'Agostino; R Curtis Ellison; Caroline S Fox
Journal:  Gastroenterology       Date:  2008-09-20       Impact factor: 22.682

View more
  49 in total

1.  Nonalcoholic fatty liver disease: liver disease: an overlooked complication of diabetes mellitus.

Authors:  Marco Arrese
Journal:  Nat Rev Endocrinol       Date:  2010-12       Impact factor: 43.330

Review 2.  Non-alcoholic fatty liver disease and diabetes: from physiopathological interplay to diagnosis and treatment.

Authors:  Nathalie C Leite; Cristiane A Villela-Nogueira; Claudia R L Cardoso; Gil F Salles
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Diabetes mellitis: risk factor for advanced liver disease.

Authors:  Ferhan Siddiqi; Lindsay Carter; Kevork M Peltekian
Journal:  CMAJ       Date:  2011-03-22       Impact factor: 8.262

Review 4.  Hyponatremia in patients with liver diseases: not just a cirrhosis-induced hemodynamic compromise.

Authors:  G Liamis; T D Filippatos; A Liontos; M S Elisaf
Journal:  Hepatol Int       Date:  2016-06-21       Impact factor: 6.047

5.  A key problem and challenge for hepatology: Obesity-related metabolic liver diseases.

Authors:  Yasemin Hatice Balaban
Journal:  World J Hepatol       Date:  2011-06-27

Review 6.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 7.  Enzymatic and nonenzymatic protein acetylations control glycolysis process in liver diseases.

Authors:  Juan Li; Tongxin Wang; Jun Xia; Weilei Yao; Feiruo Huang
Journal:  FASEB J       Date:  2019-08-01       Impact factor: 5.191

8.  Non-Alcoholic Fatty Liver Disease in Early Pregnancy Predicts Dysglycemia in Mid-Pregnancy: Prospective Study.

Authors:  Leanne R De Souza; Howard Berger; Ravi Retnakaran; Paraskevi A Vlachou; Jonathon L Maguire; Avery B Nathens; Philip W Connelly; Joel G Ray
Journal:  Am J Gastroenterol       Date:  2016-03-15       Impact factor: 10.864

9.  Liver and diabetes. A vicious circle.

Authors:  Paola Loria; Amedeo Lonardo; Frank Anania
Journal:  Hepatol Res       Date:  2013-01       Impact factor: 4.288

Review 10.  Review article: emerging anti-fibrotic therapies in the treatment of non-alcoholic steatohepatitis.

Authors:  M Noureddin; Q M Anstee; R Loomba
Journal:  Aliment Pharmacol Ther       Date:  2016-04-08       Impact factor: 8.171

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.